CD45RO+ Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer

CD45RO+ Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer

Tumor-infiltrating lymphocytes (TILs) are vital in limiting cancer progression and may supplement the TNM classification. CD45RO+ memory TILs show major prognostic impact in various malignancies but have not been extensively explored in non–small cell lung cancer (NSCLC). In this study, we aimed to...

Full description

Bibliographic Details
Main Authors:	Erna-Elise Paulsen, Thomas Kilvaer, Mehrdad Rakaee Khanehkenari, Ramona Johansen Maurseth, Samer Al-Saad, Sigurd M. Hald, Khalid Al-Shibli, Sigve Andersen, Elin Richardsen, Lill-Tove Busund, Roy Bremnes, Tom Donnem
Format:	Article
Language:	English
Published:	Elsevier 2015-11-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558615001414

Similar Items

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
by: Samer Al-Saad, et al.
Published: (2017-01-01)

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
by: Mehrdad Rakaee, et al.
Published: (2019-03-01)

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
by: Thomas K Kilvaer, et al.
Published: (2015-01-01)

Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
by: Erna-Elise Paulsen, et al.
Published: (2023-04-01)

Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.
by: Sigve Andersen, et al.
Published: (2017-01-01)

Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.
by: Sigve Andersen, et al.
Published: (2011-01-01)

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort.
by: Elin Richardsen, et al.
Published: (2017-01-01)

Prognostic impact of lymphocytes in soft tissue sarcomas.
by: Sveinung W Sorbye, et al.
Published: (2011-01-01)

Overexpression of miR-20a-5p in Tumor Epithelium Is an Independent Negative Prognostic Indicator in Prostate Cancer—A Multi-Institutional Study
by: Maria J. Stoen, et al.
Published: (2021-08-01)

High expression of microRNA-126 relates to favorable prognosis for colon cancer patients
by: Hallgeir Selven, et al.
Published: (2021-05-01)

Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.
by: Sveinung W Sorbye, et al.
Published: (2012-01-01)

Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
by: Thomas Karsten Kilvaer, et al.
Published: (2018-01-01)

Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
by: Christian Melbø-Jørgensen, et al.
Published: (2014-01-01)

Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
by: Thomas K Kilvaer, et al.
Published: (2010-01-01)

Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by <it>in Situ </it>Hybridization
by: Al-Saad Samer, et al.
Published: (2011-01-01)

Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients
by: Smeland Eivind, et al.
Published: (2011-07-01)

The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas
by: Valkov Andrej, et al.
Published: (2011-11-01)

The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas.
by: Andrej Valkov, et al.
Published: (2011-01-01)

Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer
by: Richardsen Elin, et al.
Published: (2012-02-01)

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC
by: Thomas Karsten Kilvaer, et al.
Published: (2019-07-01)

Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
by: Richardsen, E, et al.
Published: (2019)

Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer
by: Donnem, T, et al.
Published: (2012)

Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.
by: Donnem, T, et al.
Published: (2012)

High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
by: Hallgeir Selven, et al.
Published: (2023-02-01)

High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
by: Hallgeir Selven, et al.
Published: (2022-04-01)

Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
by: Line Moi, et al.
Published: (2019-10-01)

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
by: Carine El Sissy, et al.
Published: (2021-03-01)

Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore
by: Joseph Willis, et al.
Published: (2023-08-01)

Prognostic significance of immunoscore related markers in bladder cancer
by: Ali Ariafar, et al.
Published: (2022-08-01)

Usefulness and robustness of Immunoscore for personalized management of cancer patients
by: Florence Marliot, et al.
Published: (2020-01-01)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
by: Xiangjun Tang, et al.
Published: (2020-11-01)

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer
by: Elise F. Nassif, et al.
Published: (2021-01-01)

A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images
by: Nikita Shvetsov, et al.
Published: (2022-06-01)

A prognostic value of CD45RA+, CD45RO+, CCL20+ and CCR6+ expressing cells as ‘immunoscore’ to predict cervical cancer induced by HPV
by: Ana Teresa G. Fernandes, et al.
Published: (2021-04-01)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
by: Zihuan Zhao, et al.
Published: (2020-05-01)

Cancer classification using the Immunoscore: a worldwide task force
by: Galon Jérôme, et al.
Published: (2012-10-01)

The consensus immunoscore: toward a new classification of colorectal cancer
by: Anastasia Lanzi, et al.
Published: (2020-01-01)

Revision of the TNM Stage Grouping in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
by: Bo YE, et al.
Published: (2016-06-01)

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
by: Assia Hijazi, et al.
Published: (2023-12-01)

A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer
by: Wei Jiang, et al.
Published: (2023-09-01)